Madras Agricultural Journal
Loading.. Please wait
Research Article | Open Access | Peer Review

Phytochemical and In-Silico Evaluation of the Pharmaceutically Important Biomolecules Present in Leaf and Seed Extracts of Mucuna pruriens

Reuben-kalu J I Renuka R Uma D Gnanam R SanthanakrishnanV P Alum E A
Volume : 108
Issue: December(10-12)
Pages: 1 -
Downloads: 0
Published: April 06, 2022
Download

Warning: Undefined variable $sections_data in /var/www/html/view_journal.php on line 921

Warning: foreach() argument must be of type array|object, null given in /var/www/html/view_journal.php on line 130

Warning: Undefined variable $sections_data in /var/www/html/view_journal.php on line 930

Warning: foreach() argument must be of type array|object, null given in /var/www/html/view_journal.php on line 130

Abstract


The present research aimed to identify the bioactive compounds presentin two varieties of Mucuna pruriens var utilis (IIHR Selection 3 and ArkaDhanvantari) and their pharmaceutical importance evaluated throughphytochemical and in-silico screening. The phytochemical screening of theleaf and seed extracts revealed the presence of alkaloids, tannins, flavonoids,phenols, proteins, terpenoids, glycosides, steroids, saponins etc. A total of 43compounds were identified in the gas chromatography and mass spectrometry(GC-MS) analysis, and the identified biological active compounds were usedfor in-silico analysis. In-silico docking study revealed potent inhibition of theselected compounds: alpha-D-glucopyranoside, ethyl iso-allocholate andsitosterol against uncoupling protein 2 receptor (UCP2) involved in type 2diabetes, showing that the binding profiles towards key amino acid residues inthe active site were similar to that of the commercial alpha-amylase inhibitors:voglibose, acarbose and glibenclamide. Furthermore, the potent inhibitionof another selected compound: 3-(4-hydroxyphenyl) propanoic acid againstDJ-1 receptor (PARK7) involved in Parkinson’s disease was determined bydocking and it was observed that the binding profile towards key aminoacid residues in the active site was similar to that of commercial levodopa.Therefore, M. Pruriens extracts can be explored in managing type-2 diabetesand Parkinson’s disease.

DOI
Pages
1 -
Creative Commons
Copyright
© The Author(s), 2025. Published by Madras Agricultural Students' Union in Madras Agricultural Journal (MAJ). This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited by the user.

Keywords


Mucuna pruriens; GC-MS; Biomolecules; Ligand-based docking; Type-2 diabetes; Parkinson’s disease
footer

Copyright © Madras Agricultural Journal | Masu Journal All rights reserved.